Myxothiazol, a new antibiotic interfering with respiration
- 1 April 1981
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 19 (4) , 504-507
- https://doi.org/10.1128/aac.19.4.504
Abstract
Myxothiazol, a new antibiotic from the myxobacterium Myxococcus fulvus, inhibited the growth of mnay yeasts and fungi at concentrations between 0.01-3 .mu.g/ml. It was generally inactive against bacteria. The inhibitory effect was cytostatic. With Candida albicans, Saccharomyces cerevisiae and Mucor hiemalis, the growth inhibition was neutralized by glucose. Soon after being added to a cell suspension, the compound almost completely blocked O2 consumption.This publication has 6 references indexed in Scilit:
- Myxothiazol, an antibiotic from Myxococcus fulvus. (myxobacterales) II. Structure elucidation.The Journal of Antibiotics, 1980
- Myxothiazol, an antibiotic from myxococcus fulvus. (myxobacterales) I. cultivation, isolation, physico-chemical and biological properties.The Journal of Antibiotics, 1980
- The alternate respiratory pathway of Candida albicansArchiv für Mikrobiologie, 1978
- Ophiocordin, an antifungal antibiotic of Cordyceps ophioglossoidesArchiv für Mikrobiologie, 1977
- Mode of action of mucidin, a new antifungal antibiotic produced by the basidiomycete Oudemansiella mucidaBiochimica et Biophysica Acta (BBA) - General Subjects, 1974
- STUDIES ON THE BIOLOGICAL ACTION OF ANTIMYCIN-A1950